Header cover image

Australian Pharmaceuticals & Biotech Profitable Climbers

Results

4

0 new

4 companies

Neuren Pharmaceuticals

Market Cap: AU$2.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$20.25

7D

-0.4%

1Y

5.1%

Medical Developments International

Market Cap: AU$56.3m

Provides emergency medical solutions in Australia, Europe, the United States, and internationally.

MVP

AU$0.50

7D

3.1%

1Y

-15.3%

Aroa Biosurgery

Market Cap: AU$190.2m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.55

7D

-0.9%

1Y

-21.4%

Telix Pharmaceuticals

Market Cap: AU$5.3b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

TLX

AU$15.67

7D

-4.9%

1Y

14.5%